159 related articles for article (PubMed ID: 9323715)
1. Ocular gene therapy: experimental studies and clinical possibilities.
Murata T; Kimura H; Sakamoto T; Osusky R; Spee C; Stout TJ; Hinton DR; Ryan SJ
Ophthalmic Res; 1997; 29(5):242-51. PubMed ID: 9323715
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy in ocular diseases.
Singh VK; Tripathi P
Indian J Ophthalmol; 2002 Sep; 50(3):173-81. PubMed ID: 12355690
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferative vitreoretinopathy.
Kimura H; Sakamoto T; Cardillo JA; Spee C; Hinton DR; Gordon EM; Anderson WF; Ryan SJ
Hum Gene Ther; 1996 May; 7(7):799-808. PubMed ID: 8860832
[TBL] [Abstract][Full Text] [Related]
4. [Gene transfer in ophthalmology].
Reichel MB; Hudde T; Ali RR; Wiedemann P
Ophthalmologe; 1999 Sep; 96(9):570-7. PubMed ID: 10501984
[TBL] [Abstract][Full Text] [Related]
5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.
Pepose JS; Leib DA
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2662-6. PubMed ID: 8188460
[No Abstract] [Full Text] [Related]
7. Gene therapy for metastatic malignant melanoma: evaluation of tolerance to intratumoral injection of cells producing recombinant retroviruses carrying the herpes simplex virus type 1 thymidine kinase gene, to be followed by ganciclovir administration.
Klatzmann D
Hum Gene Ther; 1996 Jan; 7(2):255-67. PubMed ID: 8788175
[TBL] [Abstract][Full Text] [Related]
8. Treatment of ocular disorders by gene therapy.
Solinís MÁ; del Pozo-Rodríguez A; Apaolaza PS; Rodríguez-Gascón A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):331-42. PubMed ID: 25536112
[TBL] [Abstract][Full Text] [Related]
9. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for ocular disease.
Bennett J; Maguire AM
Mol Ther; 2000 Jun; 1(6):501-5. PubMed ID: 10933974
[No Abstract] [Full Text] [Related]
11. An experimental application of gene therapy for human retinoblastoma.
Hayashi N; Ido E; Ohtsuki Y; Ueno H
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):265-72. PubMed ID: 9950583
[TBL] [Abstract][Full Text] [Related]
12. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
13. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy against an experimental glioma using adeno-associated virus vectors.
Okada H; Miyamura K; Itoh T; Hagiwara M; Wakabayashi T; Mizuno M; Colosi P; Kurtzman G; Yoshida J
Gene Ther; 1996 Nov; 3(11):957-64. PubMed ID: 8940635
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
16. Killing Epstein-Barr virus-positive B lymphocytes by gene therapy: comparing the efficacy of cytosine deaminase and herpes simplex virus thymidine kinase.
Rogers RP; Ge JQ; Holley-Guthrie E; Hoganson DK; Comstock KE; Olsen JC; Kenney S
Hum Gene Ther; 1996 Dec; 7(18):2235-45. PubMed ID: 8953314
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy prospects in ophthalmology].
Stopa M
Klin Oczna; 2002; 104(3-4):289-92. PubMed ID: 12608321
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for ocular diseases.
Liu MM; Tuo J; Chan CC
Br J Ophthalmol; 2011 May; 95(5):604-12. PubMed ID: 20733027
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated suicide gene transduction: feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits.
Malecaze F; Couderc B; de Neuville S; Serres B; Mallet J; Douin-Echinard V; Manenti S; Revah F; Darbon JM
Hum Gene Ther; 1999 Sep; 10(14):2365-72. PubMed ID: 10515456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
